The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancer

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells

(2011) Brian M. Olson et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunotherapy for Prostate Cancer: Recent Advances, Lessons Learned, and Areas for Further Research

(2011) J. L. Gulley et al.   CLINICAL CANCER RESEARCH

Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants

(2011) Elahe A. Mostaghel et al.   CLINICAL CANCER RESEARCH

Abiraterone and Increased Survival in Metastatic Prostate Cancer

(2011) Johann S. de Bono et al.   NEW ENGLAND JOURNAL OF MEDICINE

HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase

(2010) Brian M. Olson et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity

(2010) Hiromitsu Kawata et al.   PROSTATE

Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy

(2009) M. P. Steinkamp et al.   CANCER RESEARCH

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer

(2009) Michael A Morse et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses

(2009) Ana Paula de Souza et al.   Expert Review of Anticancer Therapy

Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer

(2009) Douglas G. McNeel et al.   JOURNAL OF CLINICAL ONCOLOGY

Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer

(2009) Mary L. Disis et al.   JOURNAL OF CLINICAL ONCOLOGY

Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages

(2009) Andrew Gray et al.   VACCINE

Effective Inhibition of the Epidermal Growth Factor/Epidermal Growth Factor Receptor Binding by Anti-Epidermal Growth Factor Antibodies Is Related to Better Survival in Advanced Non-Small-Cell Lung Cancer Patients Treated with the Epidermal Growth Factor Cancer Vaccine

(2008) B. Garcia et al.   CLINICAL CANCER RESEARCH

Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer

(2008) H. L. Kaufman et al.   CLINICAL CANCER RESEARCH

Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma

(2008) J. L. Gulley et al.   CLINICAL CANCER RESEARCH

A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting

(2008) Andrew Gray et al.   IMMUNOLOGICAL REVIEWS